These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1336722)

  • 1. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.
    Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Alexandrov K; Rojas M; Saracci R; Giuntini C
    Environ Health Perspect; 1992 Nov; 98():119-24. PubMed ID: 1336722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients.
    Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Geneste O; Camoirano A; Saracci R; Giuntini C
    Mutat Res; 1991; 250(1-2):103-14. PubMed ID: 1944327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
    Petruzzelli S; Camus AM; Carrozzi L; Ghelarducci L; Rindi M; Menconi G; Angeletti CA; Ahotupa M; Hietanen E; Aitio A
    Cancer Res; 1988 Aug; 48(16):4695-700. PubMed ID: 3135117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer.
    Bartsch H; Castegnaro M; Rojas M; Camus AM; Alexandrov K; Lang M
    Toxicol Lett; 1992 Dec; 64-65 Spec No():477-83. PubMed ID: 1471200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monooxygenase, epoxide hydrolase, and glutathione-S-transferase activities in human lung. Variation between groups of bronchogenic carcinoma and non-cancer patients and interindividual differences.
    Oesch F; Schmassmann H; Ohnhaus E; Althaus U; Lorenz J
    Carcinogenesis; 1980; 1(10):827-35. PubMed ID: 11219854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer.
    Nakajima T; Elovaara E; Anttila S; Hirvonen A; Camus AM; Hayes JD; Ketterer B; Vainio H
    Carcinogenesis; 1995 Apr; 16(4):707-11. PubMed ID: 7728947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon hydroxylase activity in human lung tissue: in relation to cigarette smoking and lung cancer.
    Yoshikawa M; Arashidani K; Kawamoto T; Kodama Y
    Environ Res; 1994 Apr; 65(1):1-11. PubMed ID: 8162876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of smoking on benzo(alpha)pyrene- and glutathione-metabolizing enzymes in human lung tissue.
    Bluhm C
    Klin Wochenschr; 1991 Nov; 69(18):819-24. PubMed ID: 1663186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans.
    Bartsch H; Rojas M; Alexandrov K; Camus AM; Castegnaro M; Malaveille C; Anttila S; Hirvonen K; Husgafvel-Pursiainen K; Hietanen E
    Pharmacogenetics; 1995; 5 Spec No():S84-90. PubMed ID: 7581496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible prognostic value of pulmonary AH-locus-linked enzymes in patients with tobacco-related lung cancer.
    Bartsch H; Hietanen E; Petruzzelli S; Giuntini C; Saracci R; Mussi A; Angeletti CA
    Int J Cancer; 1990 Aug; 46(2):185-8. PubMed ID: 2384269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients.
    Anttila S; Vainio H; Hietanen E; Camus AM; Malaveille C; Brun G; Husgafvel-Pursiainen K; Heikkilä L; Karjalainen A; Bartsch H
    Environ Health Perspect; 1992 Nov; 98():179-82. PubMed ID: 1336724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cigarette smoke on aryl hydrocarbon hydroxylase activity and cytochrome P450 content in rat liver and lung microsomes.
    Kushinsky R; Louis CJ
    Oncology; 1976; 33(5-6):197-200. PubMed ID: 1026852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of the mutagenic/carcinogenic action of cigarette smoke at the pulmonary level: enzymatic induction, activation and detoxification].
    Scassellati Sforzolini G; Pasquini R; Savino A; Monarca S
    Ann Ig; 1989; 1(1-2):295-311. PubMed ID: 2483074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
    Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
    Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogenetic variation in rat liver, lung and kidney monooxygenase induction by low doses of benzo(A)pyrene and cigarette-smoke condensate.
    van Cantfort J; Gielen JE
    Br J Cancer; 1981 Dec; 44(6):902-10. PubMed ID: 6275873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A role of aryl hydrocarbon hydroxylase inducibility in susceptibility to lung carcinogenesis].
    Kiyohara C; Hirohata T
    Nihon Eiseigaku Zasshi; 1994 Feb; 48(6):1027-36. PubMed ID: 8126925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
    Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
    Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.